Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Tezspire 210 mg solution for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
tezepelumab
Company:  
AstraZeneca UK Limited See contact details
ATC code: 
R03DX11
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual HCP Med Info
{arrow_left}
{arrow_right}

The user manual gives instructions on how to safely and effectively administer your medicine. It should be read in conjunction with the patient leaflet.

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.


{pdf} View or print the user manual as PDF
AstraZeneca UK Limited
Company image
Address
2 Pancras Square, 8th Floor, London, N1C 4AG, UK
Telephone
+44 (0)1582 836 000
Fax
+44 (0)1582 838 000
Medical Information Direct Line
0800 783 0033
Medical Information e-mail
[email protected]
Medical Information Website
https://medicalinformation.astrazeneca.co.uk/
Medical Information Website
www.myazmed.co.uk